Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A new missense mutation c.1240A>G in fumarate hydratase gene leads to uterine leiomyoma associated hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome in Chinese. | Transl Oncol | 2024 | 38663218 | PubTator, text mining | PubMed |
| Germline and Somatic Fumarate Hydratase Testing in Atypical Uterine Leiomyomata. | Cancer Prev Res (Phila) | 2024 | 38638033 | PubTator, text mining | PubMed |
| Fumarate hydratase mutation associated uterine leiomyomas: A case report and literature review. | Clin Case Rep | 2024 | 38590329 | PubTator, text mining | PubMed |
| The New WHO Category of "Molecularly Defined Renal Carcinomas": Clinical and Diagnostic Features and Management Implications. | Urol Oncol | 2024 | 38519377 | PubTator, text mining | PubMed |
| Genetically driven predisposition leads to an unusually genomic unstable renal cell carcinoma. | Discov Oncol | 2024 | 38512353 | PubTator, text mining | PubMed |
| Knowledge-Based Therapeutics for Tricarboxylic Acid (TCA) Cycle-Deficient Cancers. | Cold Spring Harb Perspect Med | 2024 | 38503501 | PubTator, text mining | PubMed |
| Uterine Leiomyosarcoma Associated With Perivascular Epithelioid Cell Tumor: A Phenomenon of Differentiation/Dedifferentiation and Evidence Suggesting Cell-of-Origin. | Am J Surg Pathol | 2024 | 38497360 | PubTator, text mining | PubMed |
| Bilateral fumarate hydratase deficient renal cell carcinoma in a patient with hereditary leiomyomatosis and renal cell cancer syndrome. | IJU Case Rep | 2024 | 38440695 | PubTator, text mining | PubMed |
| Fumarate Hydratase Enhances the Therapeutic Effect of PD-1 Antibody in Colorectal Cancer by Regulating PCSK9. | Cancers (Basel) | 2024 | 38398104 | PubTator, text mining | PubMed |
| Fumarate Hydratase-Deficient Renal Cell Carcinoma With Predominant Tubulocystic Features Mimics Tubulocystic Renal Cell Carcinoma. | Arch Pathol Lab Med | 2024 | 38390749 | PubTator, text mining | PubMed |
| The role of promoter methylation of the genes encoding the enzymes metabolizing di- and tricarboxylic acids in the regulation of plant respiration by light. | J Plant Physiol | 2024 | 38377939 | PubTator, text mining | PubMed |
| Fumarate induces LncRNA-MIR4435-2HG to regulate glutamine metabolism remodeling and promote the development of FH-deficient renal cell carcinoma. | Cell Death Dis | 2024 | 38374146 | PubTator, text mining | PubMed |
| Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma. | NAR Cancer | 2024 | 38328795 | PubTator, text mining | PubMed |
| FH deficient uterine leiomyomas-a case series. | Heliyon | 2024 | 38293425 | PubTator, text mining | PubMed |
| Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma. | J Bone Oncol | 2024 | 38288377 | PubTator, text mining | PubMed |
| Cancer metabolism and carcinogenesis. | Exp Hematol Oncol | 2024 | 38287402 | PubTator, text mining | PubMed |
| AKR1B1 drives hyperglycemia-induced metabolic reprogramming in MASLD-associated hepatocellular carcinoma. | JHEP Rep | 2024 | 38283757 | PubTator, text mining | PubMed |
| Sugar or Spice, Siblings are Bitter or Nice! | Indian Dermatol Online J | 2024 | 38283015 | PubTator, text mining | PubMed |
| Prognostic and immune predictive roles of a novel tricarboxylic acid cycle-based model in hepatocellular carcinoma. | Sci Rep | 2024 | 38282028 | PubTator, text mining | PubMed |
| The Effect of Race/Ethnicity and MED12 Mutation on the Expression of Long Non-Coding RNAs in Uterine Leiomyoma and Myometrium. | Int J Mol Sci | 2024 | 38279317 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=9